missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IDO1 Recombinant Rabbit Monoclonal Antibody (BLR040F)
Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA544276
This item is not returnable.
View return policy
Description
IDO1 Recombinant Monoclonal Antibody for Western Blot, IP
IDO1 is an intracellular heme-containing enzyme that catalyzes the oxidative cleavage of the indole ring of several important regulatory molecules like tryptophan, serotonin, and melatonin. By doing this, IDO1 initiates the production of biologically active metabolites, commonly referred to as kynurenines. IDO1 is widely expressed in a variety of human tissues as well as in macrophages and dendritic cells (DCs). In inflammation, interferons (IFNs) act on specific receptors to trigger IDO1 induction. The production of IFN-gamma and induction of IDO1 represent important antimicrobial mechanisms. Degradation and depletion of tryptophan by IDO1 inhibits the growth of viruses, bacteria and parasites. Furthermore, IDO1 plays a complex and crucial role in immunoregulation during infection, pregnancy, autoimmunity, transplantation, and neoplasia.
Specifications
| IDO1 | |
| Recombinant Monoclonal | |
| 0.4 mg/mL | |
| BBS with 0.1% BSA and 0.09% sodium azide; pH 7.8-8.6 | |
| P14902 | |
| Ido1 | |
| Recombinant protein representing human Indoleamine 2, 3-dioxygenase 1 (IDO1, residues 1-403). | |
| 20 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Immunoprecipitation, Western Blot | |
| BLR040F | |
| Unconjugated | |
| Ido1 | |
| EC 1.13.11.52; IDO; IDO1; IDO-1; INDO; indolamine 2,3 dioxygenase; indole 2,3-dioxygenase; indoleamine; indoleamine 2,3-dioxygenase 1; indoleamine 23-dioxygenase; Indoleamine-2; indoleamine-pyrrole 2,3 dioxygenase; indoleamine-pyrrole 2,3-dioxygenase | |
| Rabbit | |
| Purified | |
| RUO | |
| 3620 | |
| 4°C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction